GenrAb, Inc.

Private

Dallas, TexasHealthcare & Life Scienceshttps://genrab.com/

Last Round

Seed

Apr 22, 2025

Total Funding Raised

$5.6M

Company Overview

GenrAb, Inc. is a biotechnology company that develops neuroprotective therapies by harnessing the human immune system to identify fully-human monoclonal antibodies for the treatment of neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologymonoclonal antibodydrug discoverybiotechneuroprotectionantibody therapeuticsneurodegenerative diseaseAGSantibody gene signatureblood-brain barrierbiotech startupdrug pipelinetherapeutic antibodyneuroscience startupcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenrAb, Inc. Comps

Public and private peers based on sector, stage, and business model.

GenrAb, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GenrAb, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Apr 22, 2025

View all Funding Rounds

GenrAb, Inc. Investors

Notable investors and investment history

GenrAb, Inc. investors
Investor	Rounds
Actium Group	Seed
Salem Partners	Seed
Research Bridge Partners	Seed
JMS Capital	Seed
Green Park & Golf Ventures	Seed

View all Investors

GenrAb, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GenrAb, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenrAb, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas

Year Founded2022

Last FundingApr 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.